GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.01 $4.17 Friday, 19th Apr 2024 CLRB stock ended at $3.03. This is 0.329% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.98% from a day low at $3.01 to a day high of $3.16.
90 days $3.01 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
2024-02-07 $3.56 $3.56 $3.42 $3.53 553 676
2024-02-06 $3.40 $3.59 $3.40 $3.55 521 899
2024-02-05 $3.70 $3.70 $3.36 $3.42 1 939 716
2024-02-02 $3.84 $3.96 $3.67 $3.76 1 152 442
2024-02-01 $4.01 $4.01 $3.72 $3.93 1 298 429
2024-01-31 $3.95 $4.23 $3.90 $3.91 1 628 755
2024-01-30 $4.19 $4.38 $3.90 $3.97 1 265 482
2024-01-29 $3.69 $4.28 $3.66 $4.21 2 869 666
2024-01-26 $3.60 $3.81 $3.50 $3.75 1 601 935
2024-01-25 $3.40 $3.59 $3.33 $3.59 1 175 063
2024-01-24 $3.74 $3.74 $3.35 $3.36 1 873 294
2024-01-23 $3.66 $3.76 $3.54 $3.69 1 158 207
2024-01-22 $3.55 $3.89 $3.53 $3.64 3 078 390
2024-01-19 $3.48 $3.61 $3.38 $3.48 1 189 861
2024-01-18 $3.42 $3.57 $3.35 $3.54 730 088
2024-01-17 $3.69 $3.73 $3.33 $3.40 2 077 150
2024-01-16 $3.49 $3.80 $3.42 $3.70 2 577 043
2024-01-12 $3.40 $3.57 $3.33 $3.51 1 196 231
2024-01-11 $3.50 $3.57 $3.23 $3.44 1 858 983
2024-01-10 $3.70 $3.78 $3.30 $3.47 2 795 064
2024-01-09 $3.28 $3.74 $3.26 $3.65 5 025 062
2024-01-08 $3.12 $3.59 $2.92 $3.20 30 920 466
2024-01-05 $2.91 $2.91 $2.55 $2.71 2 133 373
2024-01-04 $2.89 $3.06 $2.78 $2.83 1 444 579
2024-01-03 $2.95 $3.13 $2.80 $2.83 1 879 165
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT